[go: up one dir, main page]

SK74195A3 - Amine derivatives, method of their production, their use for production of pharmaceutical agents and pharmaceutical agents with their contents - Google Patents

Amine derivatives, method of their production, their use for production of pharmaceutical agents and pharmaceutical agents with their contents Download PDF

Info

Publication number
SK74195A3
SK74195A3 SK741-95A SK74195A SK74195A3 SK 74195 A3 SK74195 A3 SK 74195A3 SK 74195 A SK74195 A SK 74195A SK 74195 A3 SK74195 A3 SK 74195A3
Authority
SK
Slovakia
Prior art keywords
formula
phenyl
oxo
dcm
solution
Prior art date
Application number
SK741-95A
Other languages
English (en)
Slovak (sk)
Inventor
Duncan R Armour
Philip C Box
Pritom Shah
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SK74195A3 publication Critical patent/SK74195A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK741-95A 1992-12-05 1993-12-02 Amine derivatives, method of their production, their use for production of pharmaceutical agents and pharmaceutical agents with their contents SK74195A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929225492A GB9225492D0 (en) 1992-12-05 1992-12-05 Amine derivatives
PCT/EP1993/003381 WO1994013648A1 (en) 1992-12-05 1993-12-02 1,4-benzodiazepine derivatives and their use as cck-modulators

Publications (1)

Publication Number Publication Date
SK74195A3 true SK74195A3 (en) 1995-11-08

Family

ID=10726205

Family Applications (1)

Application Number Title Priority Date Filing Date
SK741-95A SK74195A3 (en) 1992-12-05 1993-12-02 Amine derivatives, method of their production, their use for production of pharmaceutical agents and pharmaceutical agents with their contents

Country Status (29)

Country Link
US (1) US5569654A (sh)
EP (1) EP0672037B1 (sh)
JP (1) JPH08504200A (sh)
KR (1) KR950704270A (sh)
CN (1) CN1093085A (sh)
AT (1) ATE168102T1 (sh)
AU (1) AU688295B2 (sh)
BG (1) BG99696A (sh)
BR (1) BR9307580A (sh)
CA (1) CA2150461A1 (sh)
CZ (1) CZ138495A3 (sh)
DE (1) DE69319614D1 (sh)
EC (1) ECSP941085A (sh)
FI (1) FI952709A (sh)
GB (1) GB9225492D0 (sh)
HU (1) HUT71339A (sh)
IL (1) IL107869A (sh)
MX (1) MX9307654A (sh)
NO (1) NO952208L (sh)
NZ (1) NZ258874A (sh)
OA (1) OA10161A (sh)
PE (1) PE54294A1 (sh)
PL (1) PL309281A1 (sh)
RO (1) RO114446B1 (sh)
RU (1) RU95114528A (sh)
SK (1) SK74195A3 (sh)
TW (1) TW237450B (sh)
WO (1) WO1994013648A1 (sh)
ZA (1) ZA939068B (sh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
US5428157A (en) * 1993-11-22 1995-06-27 Merck & Co., Inc. 3-acylaminobenzodiazepines
US5795887A (en) * 1994-04-15 1998-08-18 Glaxo Wellcome Inc. Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds
US5807876A (en) * 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
AUPO284396A0 (en) * 1996-10-08 1996-10-31 Fujisawa Pharmaceutical Co., Ltd. Benzodiazepine derivatives
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
AU6896398A (en) 1997-04-14 1998-11-11 Cor Therapeutics, Inc. Selective factor xa inhibitors
NZ500353A (en) 1997-04-14 2002-02-01 Cor Therapeutics Inc Cyclic diaza compounds that are selective inhibitors of factor Xa
WO1998046591A1 (en) 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6333321B1 (en) * 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6100254A (en) * 1997-10-10 2000-08-08 Board Of Regents, The University Of Texas System Inhibitors of protein tyrosine kinases
ES2281527T3 (es) * 2001-05-25 2007-10-01 Cephalon, Inc. Formulaciones farmaceuticas solidas que comprenden modafinilo.
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
WO2006062982A2 (en) * 2004-12-07 2006-06-15 Locus Pharmaceuticals, Inc. Urea inhibitors of map kinases
CA2589274A1 (en) * 2004-12-07 2006-06-15 Locus Pharmaceuticals, Inc. Inhibitors of protein kinases
JP2009522363A (ja) * 2006-01-04 2009-06-11 ローカス ファーマシューティカルズ、インク. プロテインキナーゼの阻害剤
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032226A1 (en) * 1989-12-18 1991-06-19 Mark G. Bock Benzodiazepine analogs
CA2068355A1 (en) * 1991-05-14 1992-11-15 Mark S. Chambers Benzodiazephine derivatives, compositions containing them and their use in therapy
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents

Also Published As

Publication number Publication date
AU5694894A (en) 1994-07-04
BG99696A (bg) 1996-01-31
PE54294A1 (es) 1995-01-06
ECSP941085A (es) 1994-12-15
NO952208L (no) 1995-08-02
GB9225492D0 (en) 1993-01-27
NO952208D0 (no) 1995-06-02
NZ258874A (en) 1996-09-25
IL107869A0 (en) 1994-04-12
HU9501622D0 (en) 1995-08-28
FI952709A (fi) 1995-08-01
MX9307654A (es) 1994-06-30
AU688295B2 (en) 1998-03-12
CN1093085A (zh) 1994-10-05
RU95114528A (ru) 1997-06-10
BR9307580A (pt) 1999-06-29
PL309281A1 (en) 1995-10-02
TW237450B (sh) 1995-01-01
OA10161A (en) 1996-12-18
CA2150461A1 (en) 1994-06-23
HUT71339A (en) 1995-11-28
CZ138495A3 (en) 1995-12-13
IL107869A (en) 1998-10-30
WO1994013648A1 (en) 1994-06-23
US5569654A (en) 1996-10-29
ZA939068B (en) 1994-08-09
RO114446B1 (ro) 1999-04-30
EP0672037A1 (en) 1995-09-20
DE69319614D1 (de) 1998-08-13
ATE168102T1 (de) 1998-07-15
KR950704270A (ko) 1995-11-17
FI952709A0 (fi) 1995-06-02
JPH08504200A (ja) 1996-05-07
EP0672037B1 (en) 1998-07-08

Similar Documents

Publication Publication Date Title
SK74195A3 (en) Amine derivatives, method of their production, their use for production of pharmaceutical agents and pharmaceutical agents with their contents
FI111632B (fi) Menetelmä CCK-B-antagonistisesti vaikuttavien 1,5-bentsodiatsepiinijohdannaisten valmistamiseksi
US5585376A (en) 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity
US5618812A (en) Benzodiazepine derivatives
PT96228A (pt) Processo para a preparacao de composicoes de analogos da benzodiazepina para o tratamento da reaccao de panico e para inducao directa da analgesia e respectivos metodos de tratamento
WO1995028399A1 (en) A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
CS240974B2 (en) Production method of n formyl a n-hydroxymethyl-3-phenoxy-1-azetidincarboxamides
RU2135485C1 (ru) Производные 1,5-бензодиазепина и содержащий их фармацевтический состав
AU742498B2 (en) 1,5-benzodiazepine derivatives
US5620972A (en) Substituted benzene derivatives
SK125495A3 (en) 1,5-benzodiazepine derivatives, manufacturing process, their use and pharmaceutical compositions containing them
US5696110A (en) Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
US5486514A (en) Carbamate derivatives
HRP940330A2 (en) Amine derivatives
AP479A (en) Amine derivatives.
SI9300328A (sl) Derivati 1,5-benzodiazepina